These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 1532198

  • 1. Treatment of bone metastases with dichloromethylene bisphosphonate.
    Francini G, Gonnelli S, Petrioli R, Conti F, Paffetti P, Gennari C.
    J Clin Oncol; 1992 Apr; 10(4):591-8. PubMed ID: 1532198
    [Abstract] [Full Text] [Related]

  • 2. Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.
    Chapuy MC, Meunier PJ, Alexandre CM, Vignon EP.
    J Clin Invest; 1980 May; 65(5):1243-7. PubMed ID: 6444955
    [Abstract] [Full Text] [Related]

  • 3. Hypercalcemia of malignancy: treatment with intravenous dichloromethylene diphosphonate.
    Jacobs TP, Siris ES, Bilezikian JP, Baquiran DC, Shane E, Canfield RE.
    Ann Intern Med; 1981 Mar; 94(3):312-6. PubMed ID: 6452846
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long-term effects of dichloromethylene diphosphonate in patients with osteolytic bone metastases and coincident primary hyperparathyroidism.
    Elomaa I, Blomqvist C, Porkka L, Holmström T, Laine H.
    Cancer Treat Rep; 1984 Apr; 68(4):655-7. PubMed ID: 6231989
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dichloromethylene diphosphonate action in hematologic and other malignancies.
    Canfield RE, Siris ES, Jacobs TP.
    Bone; 1987 Apr; 8 Suppl 1():S57-62. PubMed ID: 2961356
    [Abstract] [Full Text] [Related]

  • 8. Effects of a new aminodiphosphonate (aminohydroxybutylidene diphosphonate) in patients with osteolytic lesions from metastases and myelomatosis. Comparison with dichloromethylene diphosphonate.
    Attardo-Parrinello G, Merlini G, Pavesi F, Crema F, Fiorentini ML, Ascari E.
    Arch Intern Med; 1987 Sep; 147(9):1629-33. PubMed ID: 2957971
    [Abstract] [Full Text] [Related]

  • 9. Therapy of hypercalcemia due to parathyroid carcinoma with intravenous dichloromethylene diphosphonate.
    Shane E, Jacobs TP, Siris ES, Steinberg SF, Stoddart K, Canfield RE, Bilezikian JP.
    Am J Med; 1982 Jun; 72(6):939-44. PubMed ID: 6211978
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clodronate for osteolytic metastases due to breast cancer.
    Elomaa I, Blomqvist C, Porkka L, Holmström T, Taube T, Lamberg-Allardt C, Borgström GH.
    Biomed Pharmacother; 1988 Jun; 42(2):111-6. PubMed ID: 2971403
    [Abstract] [Full Text] [Related]

  • 12. Effects of dichloromethylene diphosphonate in women with breast carcinoma metastatic to the skeleton.
    Siris ES, Hyman GA, Canfield RE.
    Am J Med; 1983 Mar; 74(3):401-6. PubMed ID: 6219577
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hypercalcemia in malignancies: treatment with dichloromethylene diphosphonate (Cl2MDP).
    Conte N, Di Virgilio R, Roiter I, Caberlotto L.
    Tumori; 1985 Feb 28; 71(1):51-4. PubMed ID: 3157251
    [Abstract] [Full Text] [Related]

  • 15. Parenteral diphosphonates for treating malignant hypercalcemia.
    Jung A, van Ouwenaller C, Chantraine A, Courvoisier B.
    Cancer; 1981 Oct 15; 48(8):1922-5. PubMed ID: 6456809
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of dichloromethylene diphosphonate on serum and urinary calcium in primary hyperparathyroidism.
    Shane E, Baquiran DC, Bilezikian JP.
    Ann Intern Med; 1981 Jul 15; 95(1):23-7. PubMed ID: 6264825
    [Abstract] [Full Text] [Related]

  • 19. Multiple myeloma: effect of daily dichloromethylene bisphosphonate on skeletal complications.
    Clemens MR, Fessele K, Heim ME.
    Ann Hematol; 1993 Mar 15; 66(3):141-6. PubMed ID: 8471660
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.